Energization by multiple substrates and calcium challenge reveal dysfunctions in brain mitochondria in a model related to acute psychosis

Adler CM, Goldberg TE, Malhotra AK, Pickar D, Breier A (1998) Effects of ketamine on thought disorder, working memory, and semantic memory in healthy volunteers. Biol Psychiatry 43(11):811–816 Allen RM, Young SJ (1978) Phencyclidine-induced psychosis. Am J Psychiatry 135(9):1081–1084. https://doi.org/10.1176/ajp.135.9.1081 Andine P, Widermark N, Axelsson R, Nyberg G, Olofsson U, Martensson E, Sandberg M (1999) Characterization of MK-801-induced behavior as a putative rat model of psychosis. J Pharmacol Exp Ther 290(3):1393–1408 Ben-Shachar D, Karry R (2007) Sp1 expression is disrupted in schizophrenia; a possible mechanism for the abnormal expression of mitochondrial complex I genes, NDUFV1 and NDUFV2. PLoS One 2(9):e817. https://doi.org/10.1371/journal.pone.0000817 Bergman O, Ben-Shachar D (2016) Mitochondrial oxidative phosphorylation system (OXPHOS) deficits in schizophrenia: possible interactions with cellular processes. Can J Psychiatr 61(8):457–469. https://doi.org/10.1177/0706743716648290 Braff DL, Geyer MA (1990) Sensorimotor gating and schizophrenia. Human and animal model studies. Arch Gen Psychiatry 47(2):181–188 Breier A, Adler CM, Weisenfeld N, Su TP, Elman I, Picken L, Malhotra AK, Pickar D (1998) Effects of NMDA antagonism on striatal dopamine release in healthy subjects: application of a novel PET approach. Synapse 29(2):142–147. https://doi.org/10.1002/(SICI)1098-2396(199806)29:2<142::AID-SYN5>3.0.CO;2-7 Brini M, Cali T, Ottolini D, Carafoli E (2014) Neuronal calcium signaling: function and dysfunction. Cell Mol Life Sci 71(15):2787–2814. https://doi.org/10.1007/s00018-013-1550-7 Bubber P, Hartounian V, Gibson GE, Blass JP (2011) Abnormalities in the tricarboxylic acid (TCA) cycle in the brains of schizophrenia patients. Eur Neuropsychopharmacol 21(3):254–260. https://doi.org/10.1016/j.euroneuro.2010.10.007 Bustamante J, Czerniczyniec A, Lores-Arnaiz S (2016) Ketamine effect on intracellular and mitochondrial calcium mobilization. Biocell 40:11–14 Cavelier L, Jazin EE, Eriksson I, Prince J, Bave U, Oreland L, Gyllensten U (1995) Decreased cytochrome-c oxidase activity and lack of age-related accumulation of mitochondrial DNA deletions in the brains of schizophrenics. Genomics 29(1):217–224. https://doi.org/10.1006/geno.1995.1234 Chiu PW, Lui SSY, Hung KSY, Chan RCK, Chan Q, Sham PC, Cheung EFC, Mak HKF (2018) In vivo gamma-aminobutyric acid and glutamate levels in people with first-episode schizophrenia: a proton magnetic resonance spectroscopy study. Schizophr Res 193:295–303. https://doi.org/10.1016/j.schres.2017.07.021 de Oliveira L, Spiazzi CM, Bortolin T, Canever L, Petronilho F, Mina FG, Dal-Pizzol F, Quevedo J, Zugno AI (2009) Different sub-anesthetic doses of ketamine increase oxidative stress in the brain of rats. Prog Neuro-Psychopharmacol Biol Psychiatry 33(6):1003–1008. https://doi.org/10.1016/j.pnpbp.2009.05.010 de Oliveira L, Fraga DB, De Luca RD, Canever L, Ghedim FV, Matos MP, Streck EL, Quevedo J, Zugno AI (2011) Behavioral changes and mitochondrial dysfunction in a rat model of schizophrenia induced by ketamine. Metab Brain Dis 26(1):69–77. https://doi.org/10.1007/s11011-011-9234-1 Eyjolfsson EM, Brenner E, Kondziella D, Sonnewald U (2006) Repeated injection of MK801: an animal model of schizophrenia? Neurochem Int 48(6–7):541–546. https://doi.org/10.1016/j.neuint.2005.11.019 Facundo HT, de Paula JG, Kowaltowski AJ (2005) Mitochondrial ATP-sensitive K+ channels prevent oxidative stress, permeability transition and cell death. J Bioenerg Biomembr 37(2):75–82. https://doi.org/10.1007/s10863-005-4130-1 Faizi M, Salimi A, Rasoulzadeh M, Naserzadeh P, Pourahmad J (2014) Schizophrenia induces oxidative stress and cytochrome C release in isolated rat brain mitochondria: a possible pathway for induction of apoptosis and neurodegeneration. Iran J Pharm Res 13(Suppl):93–100 Flohe L, Gunzler WA (1984) Assays of glutathione peroxidase. Methods Enzymol 105:114–121 Fraguas D, Díaz-Caneja CM, Rodríguez-Quiroga A, Arango C (2017) Oxidative stress and inflammation in early onset first episode psychosis: a systematic review and meta-analysis. Int J Neuropsychopharmacol 20(6):435–444. https://doi.org/10.1093/ijnp/pyx015 Friel DD (2000) Mitochondria as regulators of stimulus-evoked calcium signals in neurons. Cell Calcium 28(5–6):307–316. https://doi.org/10.1054/ceca.2000.0172 Gnaiger E (2014) Mitochondrial pathways and respiratory control - the blue book (Oroboros) Gnaiger E, Kuznetsov AV, Schneeberger S, Seiler R, Brandacher G, Steurer W, Margreiter R (2000) Mitochondria in the cold. In Heldmaier G, Klingenspor M (ed) Life in the Cold. Heidelberg, Berlin, New York: Springer pp 431–442 Greene R (2001) Circuit analysis of NMDAR hypofunction in the hippocampus, in vitro, and psychosis of schizophrenia. Hippocampus 11(5):569–577. https://doi.org/10.1002/hipo.1072 Harrigan SM, McGorry PD, Krstev H (2003) Does treatment delay in first-episode psychosis really matter? Psychol Med 33(1):97–110. https://doi.org/10.1017/s003329170200675x Hasbi A, O'Dowd BF, George SR (2010) Heteromerization of dopamine D2 receptors with dopamine D1 or D5 receptors generates intracellular calcium signaling by different mechanisms. Curr Opin Pharmacol 10(1):93–99. https://doi.org/10.1016/j.coph.2009.09.011 Hjelm BE, Rollins B, Mamdani F, Lauterborn JC, Kirov G, Lynch G, Gall CM, Sequeira A, Vawter MP (2015) Evidence of mitochondrial dysfunction within the complex genetic etiology of schizophrenia. Mol Neuropsychiatry 1(4):201–219. https://doi.org/10.1159/000441252 Holmgren A, Bjornstedt M (1995) Thioredoxin and thioredoxin reductase. Methods Enzymol 252:199–208 Howes O, McCutcheon R, Stone J (2015) Glutamate and dopamine in schizophrenia: an update for the 21st century. J Psychopharmacol 29(2):97–115. https://doi.org/10.1177/0269881114563634 Insel TR (2010) Rethinking schizophrenia. Nature 468(7321):187–193. https://doi.org/10.1038/nature09552 Iwamoto K, Bundo M, Kato T (2005) Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum Mol Genet 14(2):241–253. https://doi.org/10.1093/hmg/ddi022 Jonas EA, Buchanan J, Kaczmarek LK (1999) Prolonged activation of mitochondrial conductances during synaptic transmission. Science 286(5443):1347–1350 Jones CA, Watson DJ, Fone KC (2011) Animal models of schizophrenia. Br J Pharmacol 164(4):1162–1194. https://doi.org/10.1111/j.1476-5381.2011.01386.x Kirichok Y, Krapivinsky G, Clapham DE (2004) The mitochondrial calcium uniporter is a highly selective ion channel. Nature 427(6972):360–364. https://doi.org/10.1038/nature02246 Koga M, Serritella AV, Sawa A, Sedlak TW (2016) Implications for reactive oxygen species in schizophrenia pathogenesis. Schizophr Res 176(1):52–71. https://doi.org/10.1016/j.schres.2015.06.022 Korshunov SS, Skulachev VP, Starkov AA (1997) High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett 416(1):15–18 Kritis AA, Stamoula EG, Paniskaki KA, Vavilis TD (2015) Researching glutamate - induced cytotoxicity in different cell lines: a comparative/collective analysis/study. Front Cell Neurosci 9:91. https://doi.org/10.3389/fncel.2015.00091 LaFerla FM (2002) Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease. Nat Rev Neurosci 3(11):862–872. https://doi.org/10.1038/nrn960 Lahti AC, Koffel B, LaPorte D, Tamminga CA (1995) Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology 13(1):9–19. https://doi.org/10.1016/0893-133X(94)00131-I Lewis DA, Levitt P (2002) Schizophrenia as a disorder of neurodevelopment. Annu Rev Neurosci 25:409–432. https://doi.org/10.1146/annurev.neuro.25.112701.142754 Li Z, Okamoto K, Hayashi Y, Sheng M (2004) The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 119(6):873–887. https://doi.org/10.1016/j.cell.2004.11.003 Li Z, Hu M, Zong X, He Y, Wang D, Dai L, Dong M, Zhou J, Cao H, Lv L, Chen X, Tang J (2015) Association of telomere length and mitochondrial DNA copy number with risperidone treatment response in first-episode antipsychotic-naïve schizophrenia. Sci Rep 5:18553–18557. https://doi.org/10.1038/srep18553 Lidow MS (2003) Calcium signaling dysfunction in schizophrenia: a unifying approach. Brain Res Brain Res Rev 43(1):70–84 Lisek M, Boczek T, Ferenc B, Zylinska L (2016) Regional brain dysregulation of Ca(2+)-handling systems in ketamine-induced rat model of experimental psychosis. Cell Tissue Res 363(3):609–620. https://doi.org/10.1007/s00441-015-2332-3 Lodge D, Mercier MS (2015) Ketamine and phencyclidine: the good, the bad and the unexpected. Br J Pharmacol 172(17):4254–4276. https://doi.org/10.1111/bph.13222 Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193(1):265–275 Malhotra AK, Pinals DA, Adler CM, Elman I, Clifton A, Pickar D, Breier A (1997) Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics. Neuropsychopharmacology 17(3):141–150. https://doi.org/10.1016/S0893-133X(97)00036-5 Manahan-Vaughan D, von Haebler D, Winter C, Juckel G, Heinemann U (2008) A single application of MK801 causes symptoms of acute psychosis, deficits in spatial memory, and impairment of synaptic plasticity in rats. Hippocampus 18(2):125–134. https://doi.org/10.1002/hipo.20367 Mansbach RS (1991) Effects of NMDA receptor ligands on sensorimotor gating in the rat. Eur J Pharmacol 202(1):61–66 Marchbanks RM, Ryan M, Day IN, Owen M, McGuffin P, Whatley SA (2003) A mitochondrial DNA sequence variant associated with schizophrenia and oxidative stress. Schizophr Res 65(1):33–38 Martins EL, Ricardo JC, de-Souza-Ferreira E, Camacho-Pereira J, Ramos-Filho D, Galina A (2018) Rapid regulation of substrate use for oxidative phosphorylation during a single session of high intensity interval or aerobic exercises in different rat skeletal muscles. Comp Biochem Physiol B Biochem Mol Biol 217:40–50. https://doi.org/10.1016/j.cbpb.2017.11.013 Martins-De-Souza D, Dias-Neto E, Schmitt A, Falkai P, Gormanns P, Maccarrone G, Turck CW, Gattaz WF (2010) Proteome analysis of schizophrenia brain tissue. World J Biol Psychiatry 11(2):110–120. https://doi.org/10.3109/15622970903490626 Martins-de-Souza D, Harris LW, Guest PC, Bahn S (2011) The role of energy metabolism dysfunction and oxidative stress in schizophrenia revealed by proteomics. Antioxid Redox Signal 15(7):2067–2079. https://doi.org/10.1089/ars.2010.3459 Maurer I, Zierz S, Moller H (2001) Evidence for a mitochondrial oxidative phosphorylation defect in brains from patients with schizophrenia. Schizophr Res 48(1):125–136 McCord JM, Fridovich I (1969) Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 244(22):6049–6055 McCutcheon RA, Reis Marques T, Howes OD (2019) Schizophrenia - An Overview. JAMA Psychiatry 30:1–10. https://doi.org/10.1001/jamapsychiatry.2019.3360 Millo S, Chari-Bitron A (1973) Effect of phencyclidine on oxygen consumption of rat brain mitochondria in vitro and in vivo. Biochem Pharmacol 22(13):1661–1665 Mills GC (1957) Hemoglobin catabolism. I. Glutathione peroxidase, an erythrocyte enzyme which protects hemoglobin from oxidative breakdown. J Biol Chem 229(1):189–197 Mnatsakanyan N, Beutner G, Porter GA, Alavian KN, Jonas EA (2017) Physiological roles of the mitochondrial permeability transition pore. J Bioenerg Biomembr 49(1):13–25. https://doi.org/10.1007/s10863-016-9652-1 Moghaddam B, Adams B, Verma A, Daly D (1997) Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17(8):2921–2927 Murphy MP (2009) How mitochondria produce reactive oxygen species. Biochem J 417(1):1–13. https://doi.org/10.1042/BJ20081386 Neves G, Antonio CB, Betti AH, Pranke MA, Fraga CA, Barreiro EJ, Noel F, Rates SM (2013) New insights into pharmacological profile of LASSBio-579, a multi-target N-phenylpiperazine derivative active on animal models of schizophrenia. Behav Brain Res 237:86–95. https://doi.org/10.1016/j.bbr.2012.09.016 Park SJ, Lee SB, Suh Y, Kim SJ, Lee N, Hong JH, Park C, Woo Y, Ishizuka K, Kim JH, Berggren PO, Sawa A, Park SK (2017) DISC1 modulates neuronal stress responses by gate-keeping ER-mitochondria Ca(2+) transfer through the MAM. Cell Rep 21(10):2748–2759. https://doi.org/10.1016/j.celrep.2017.11.043 Penna E, Espino J, De Stefani D, Rizzuto R (2018) The MCU complex in cell death. Cell Calcium 69:73–80. https://doi.org/10.1016/j.ceca.2017.08.008 Perry BI, McIntosh G, Weich S, Singh S, Rees K (2016) The association between first-episode psychosis and abnormal glycaemic control: systematic review and meta-analysis. Lancet Psychiatry 3(11):1049–1058. https://doi.org/10.1016/S2215-0366(16)30262-0 Picchioni MM, Murray RM (2007) Schizophrenia. BMJ 335(7610):91–95. https://doi.org/10.1136/bmj.39227.616447.BE Powell SB, Zhou X, Geyer MA (2009) Prepulse inhibition and genetic mouse models of schizophrenia. Behav Brain Res 204(2):282–294. https://doi.org/10.1016/j.bbr.2009.04.021 Prabakaran S, Swatton JE, Ryan MM, Huffaker SJ, Huang JT, Griffin JL, Wayland M, Freeman T, Dudbridge F, Lilley KS, Karp NA, Hester S, Tkachev D, Mimmack ML, Yolken RH, Webster MJ, Torrey EF, Bahn S (2004) Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry 9(7):684–697, 643. https://doi.org/10.1038/sj.mp.4001511 Prince JA, Blennow K, Gottfries CG, Karlsson I, Oreland L (1999) Mitochondrial function is differentially altered in the basal ganglia of chronic schizophrenics. Neuropsychopharmacology 21(3):372–379. https://doi.org/10.1016/S0893-133X(99)00016-0 Rajasekaran A, Venkatasubramanian G, Berk M, Debnath M (2015) Mitochondrial dysfunction in schizophrenia: pathways, mechanisms and implications. Neurosci Biobehav Rev 48:10–21. https://doi.org/10.1016/j.neubiorev.2014.11.005 Rajdev S, Reynolds IJ (1993) Calcium green-5N, a novel fluorescent probe for monitoring high intracellular free Ca2+ concentrations associated with glutamate excitotoxicity in cultured rat brain neurons. Neurosci Lett 162(1–2):149–152 Regenold WT, Pratt M, Nekkalapu S, Shapiro PS, Kristian T, Fiskum G (2012) Mitochondrial detachment of hexokinase 1 in mood and psychotic disorders: implications for brain energy metabolism and neurotrophic signaling. J Psychiatr Res 46(1):95–104. https://doi.org/10.1016/j.jpsychires.2011.09.018 Rosenfeld M, Brenner-Lavie H, Ari SG, Kavushansky A, Ben-Shachar D (2011) Perturbation in mitochondrial network dynamics and in complex I dependent cellular respiration in schizophrenia. Biol Psychiatry 69(10):980–988. https://doi.org/10.1016/j.biopsych.2011.01.010 Rosenthal RE, Hamud F, Fiskum G, Varghese PJ, Sharpe S (1987) Cerebral ischemia and reperfusion: prevention of brain mitochondrial injury by lidoflazine. J Cereb Blood Flow Metab 7(6):752–758. https://doi.org/10.1038/jcbfm.1987.130 Sams-Dodd F (1996) Phencyclidine-induced stereotyped behaviour and social isolation in rats: a possible animal model of schizophrenia. Behav Pharmacol 7(1):3–23 Sawa A, Snyder SH (2002) Schizophrenia: diverse approaches to a complex disease. Science 296(5568):692–695. https://doi.org/10.1126/science.1070532 Soyka M, Koch W, Moller HJ, Ruther T, Tatsch K (2005) Hypermetabolic pattern in frontal cortex and other brain regions in unmedicated schizophrenia patients. Results from a FDG-PET study. Eur Arch Psychiatry Clin Neurosci 255(5):308–312. https://doi.org/10.1007/s00406-005-0563-0 Theberge J, Bartha R, Drost DJ, Menon RS, Malla A, Takhar J, Neufeld RW, Rogers J, Pavlosky W, Schaefer B, Densmore M, Al-Semaan Y, Williamson PC (2002) Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers. Am J Psychiatry 159(11):1944–1946. https://doi.org/10.1176/appi.ajp.159.11.1944 Tregellas JR, Smucny J, Harris JG, Olincy A, Maharajh K, Kronberg E, Eichman LC, Lyons E, Freedman R (2014) Intrinsic hippocampal activity as a biomarker for cognition and symptoms in schizophrenia. Am J Psychiatry 171(5):549–556. https://doi.org/10.1176/appi.ajp.2013.13070981 Uhlhaas PJ, Singer W (2010) Abnormal neural oscillations and synchrony in schizophrenia. Nat Rev Neurosci 11(2):100–113. https://doi.org/10.1038/nrn2774 Uranova N, Bonartsev P, Brusov O, Morozova M, Rachmanova V, Orlovskaya D (2007) The ultrastructure of lymphocytes in schizophrenia. World J Biol Psychiatry 8(1):30–37. https://doi.org/10.1080/15622970600960207 Varty GB, Higgins GA (1995) Examination of drug-induced and isolation-induced disruptions of prepulse inhibition as models to screen antipsychotic drugs. Psychopharmacology 122(1):15–26 Venancio C, Felix L, Almeida V, Coutinho J, Antunes L, Peixoto F, Summavielle T (2015) Acute ketamine impairs mitochondrial function and promotes superoxide dismutase activity in the rat brain. Anesth Analg 120(2):320–328. https://doi.org/10.1213/ANE.0000000000000539 Weiss IC, Feldon J (2001) Environmental animal models for sensorimotor gating deficiencies in schizophrenia: a review. Psychopharmacology 156(2–3):305–326 Whitton PS, Biggs CS, Pearce BR, Fowler LJ (1992) Regional effects of MK-801 on dopamine and its metabolites studied by in vivo microdialysis. Neurosci Lett 142(1):5–8 World Health Organization (WHO) (2018) Mental Health: Schizophrenia. https://www.who.int/mental_health/management/schizophrenia/en/. Accessed 17 Jan 2019 Yin F, Boveris A, Cadenas E (2014) Mitochondrial energy metabolism and redox signaling in brain aging and neurodegeneration. Antioxid Redox Signal 20(2):353–371. https://doi.org/10.1089/ars.2012.4774 Zhou K, Yang Y, Gao L, He G, Li W, Tang K, Ji B, Zhang M, Li Y, Yang J, Sun L, Zhang Z, Zhu H, He L, Wan C (2012) NMDA receptor hypofunction induces dysfunctions of energy metabolism and semaphorin signaling in rats: a synaptic proteome study. Schizophr Bull 38(3):579–591. https://doi.org/10.1093/schbul/sbq132